Pennant Group [PNTG] vs Acadia Healthcare [ACHC] Detailed Stock Comparison
Pennant Group
NASDAQ
Loading...
Acadia Healthcare
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Pennant Group wins in 3 metrics, Acadia Healthcare wins in 15 metrics, with 0 ties. Acadia Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Pennant Group | Acadia Healthcare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 29.66 | 11.84 | Acadia Healthcare |
| Price-to-Book Ratio | 2.56 | 0.53 | Acadia Healthcare |
| Debt-to-Equity Ratio | 105.10 | 73.98 | Acadia Healthcare |
| PEG Ratio | 20.87 | 4.90 | Acadia Healthcare |
| EV/EBITDA | 22.81 | 6.24 | Acadia Healthcare |
| Profit Margin (TTM) | 3.40% | 4.31% | Acadia Healthcare |
| Operating Margin (TTM) | 6.03% | 16.37% | Acadia Healthcare |
| EBITDA Margin (TTM) | 6.03% | 16.37% | Acadia Healthcare |
| Return on Equity | 11.41% | 4.83% | Pennant Group |
| Return on Assets (TTM) | 4.00% | 4.92% | Acadia Healthcare |
| Free Cash Flow (TTM) | $30.31M | $-560.69M | Pennant Group |
| 1-Year Return | -26.51% | -74.59% | Pennant Group |
| Price-to-Sales Ratio (TTM) | 1.04 | 0.51 | Acadia Healthcare |
| Enterprise Value | $1.12B | $4.02B | Acadia Healthcare |
| EV/Revenue Ratio | 1.49 | 1.25 | Acadia Healthcare |
| Gross Profit Margin (TTM) | 14.00% | 96.72% | Acadia Healthcare |
| Revenue per Share (TTM) | $23 | $35 | Acadia Healthcare |
| Earnings per Share (Diluted) | $0.76 | $1.52 | Acadia Healthcare |
| Beta (Stock Volatility) | 1.48 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Pennant Group vs Acadia Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Pennant Group | 7.75% | 8.80% | -6.69% | -13.11% | -9.29% | -8.84% |
| Acadia Healthcare | 5.82% | -16.40% | -21.96% | -24.67% | -56.63% | -55.36% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Pennant Group | -26.51% | 27.42% | -37.73% | 39.13% | 39.13% | 39.13% |
| Acadia Healthcare | -74.59% | -77.98% | -40.98% | -77.55% | 249.81% | 76.26% |
Performance & Financial Health Analysis: Pennant Group vs Acadia Healthcare
| Metric | PNTG | ACHC |
|---|---|---|
| Market Information | ||
| Market Cap | $776.93M | $1.66B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 247,939 | 2,446,030 |
| 90 Day Avg. Volume | 306,886 | 2,027,100 |
| Last Close | $25.99 | $19.26 |
| 52 Week Range | $21.18 - $37.13 | $17.13 - $82.41 |
| % from 52W High | -30.00% | -76.63% |
| All-Time High | $69.56 (Jan 04, 2021) | $89.85 (Nov 28, 2022) |
| % from All-Time High | -62.64% | -78.56% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.34% | 0.09% |
| Quarterly Earnings Growth | 0.59% | -0.62% |
| Financial Health | ||
| Profit Margin (TTM) | 0.03% | 0.04% |
| Operating Margin (TTM) | 0.06% | 0.16% |
| Return on Equity (TTM) | 0.11% | 0.05% |
| Debt to Equity (MRQ) | 105.10 | 73.98 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $8.81 | $34.08 |
| Cash per Share (MRQ) | $0.15 | $1.46 |
| Operating Cash Flow (TTM) | $17.52M | $424.81M |
| Levered Free Cash Flow (TTM) | $4.89M | $-267,724,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Pennant Group vs Acadia Healthcare
| Metric | PNTG | ACHC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 29.66 | 11.84 |
| Forward P/E | 20.87 | 4.90 |
| PEG Ratio | 20.87 | 4.90 |
| Price to Sales (TTM) | 1.04 | 0.51 |
| Price to Book (MRQ) | 2.56 | 0.53 |
| Market Capitalization | ||
| Market Capitalization | $776.93M | $1.66B |
| Enterprise Value | $1.12B | $4.02B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.49 | 1.25 |
| Enterprise to EBITDA | 22.81 | 6.24 |
| Risk & Other Metrics | ||
| Beta | 1.48 | N/A |
| Book Value per Share (MRQ) | $8.81 | $34.08 |
Financial Statements Comparison: Pennant Group vs Acadia Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | PNTG | ACHC |
|---|---|---|
| Revenue/Sales | $209.84M | $770.51M |
| Cost of Goods Sold | $180.46M | $28.34M |
| Gross Profit | $29.38M | $742.16M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $12.65M | $78.50M |
| EBITDA | $14.47M | $125.53M |
| Pre-Tax Income | $11.38M | $13.47M |
| Income Tax | $2.85M | $4.40M |
| Net Income (Profit) | $8.52M | $9.06M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | PNTG | ACHC |
|---|---|---|
| Cash & Equivalents | $5.22M | $91.24M |
| Total Current Assets | $123.89M | $638.95M |
| Total Current Liabilities | $87.97M | $473.35M |
| Long-Term Debt | $312.74M | $2.29B |
| Total Shareholders Equity | $323.03M | $3.17B |
| Retained Earnings | $65.00M | $348.45M |
| Property, Plant & Equipment | $311.61M | $597.87M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | PNTG | ACHC |
|---|---|---|
| Operating Cash Flow | $850,000 | $30.01M |
| Capital Expenditures | $-1.96M | $43,000 |
| Free Cash Flow | $-23.19M | $-163.15M |
| Debt Repayment | $-44.00M | $-1.71B |
| Common Stock Repurchase | N/A | $-46.88M |
Short Interest & Institutional Ownership Analysis
| Metric | PNTG | ACHC |
|---|---|---|
| Shares Short | 736,389 | 10.60M |
| Short Ratio | 2.56 | 5.39 |
| Short % of Float | 0.03% | 0.13% |
| Average Daily Volume (10 Day) | 247,939 | 2,446,030 |
| Average Daily Volume (90 Day) | 306,886 | 2,027,100 |
| Shares Outstanding | 34.37M | 91.78M |
| Float Shares | 29.85M | 88.65M |
| % Held by Insiders | 0.05% | 0.02% |
| % Held by Institutions | 0.93% | 1.05% |
Dividend Analysis & Yield Comparison: Pennant Group vs Acadia Healthcare
| Metric | PNTG | ACHC |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |